For the quarter ending 2025-09-30, AFCG had $41,710,324 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Accounts receivable | - | 0 |
| Net (loss) income from continuing operations | -12,490,506 | -9,096,966 |
| Provision for (reversal of) current expected credit losses | 7,372,778 | 15,152,142 |
| Realized losses (gains) on investments, net | 0 | 0 |
| Change in unrealized losses (gains) on loans at fair value, net | -9,712,427 | -1,741,448 |
| Accretion of deferred loan original issue discount and other discounts | 811,730 | 1,828,874 |
| Amortization of deferred financing costs-Line Of Credit | 41,522 | 169,393 |
| Amortization of deferred financing costs-Senior Notes | 158,964 | 313,030 |
| Stock-based compensation | 487,436 | 1,038,251 |
| Payment-in-kind interest | 151,473 | 266,550 |
| Interest receivable | -796,353 | -405,310 |
| Prepaid expenses and other assets | 733,514 | 448,170 |
| Accrued interest | 1,258,596 | 46,601 |
| Accrued management and incentive fees, net | 34,780 | -1,251,888 |
| Accrued direct administrative expenses | 56,815 | -520,473 |
| Accounts payable and other liabilities | 382,421 | 228,111 |
| Net cash provided by (used in) operating activities of continuing operations | 6,114,869 | 5,681,365 |
| Net cash provided by (used in) operating activities of discontinued operations | 0 | 0 |
| Net cash provided by (used in) operating activities | 6,114,869 | 5,681,365 |
| Issuance of and fundings on loans | 10,246,762 | 29,183,647 |
| Proceeds from sales of loans | 0 | 0 |
| Principal repayment of loans | 37,641,490 | 25,635,763 |
| Net cash provided by (used in) investing activities of continuing operations | 27,394,728 | -3,547,884 |
| Net cash (used in) provided by investing activities of discontinued operations | 0 | 0 |
| Net cash provided by (used in) investing activities | 27,394,728 | -3,547,884 |
| Proceeds from sale of common stock | 0 | - |
| Payment of offering costs - equity offering | 0 | - |
| Payment of financing costs | 10,006 | 166,928 |
| Redemption of preferred shares | 0 | 0 |
| Cash distribution in connection with the spin-off of suns | 0 | - |
| Borrowings on revolving credit facilities | 35,100,000 | 35,500,000 |
| Repayments on revolving credit facilities | 23,500,000 | 125,100,000 |
| Dividends paid to common and preferred shareholders | 3,389,267 | 12,566,948 |
| Net cash (used in) provided by financing activities of continuing operations | 8,200,727 | -102,333,876 |
| Net cash provided by (used in) financing activities of discontinued operations | 0 | 0 |
| Net cash (used in) provided by financing activities | 8,200,727 | -102,333,876 |
| Net (decrease) increase in cash and cash equivalents | 41,710,324 | -100,200,395 |
| Cash and cash equivalents at beginning of period | 103,610,460 | - |
| Cash and cash equivalents at end of period | 45,120,389 | - |
Advanced Flower Capital Inc. (AFCG)
Advanced Flower Capital Inc. (AFCG)